INTRODUCTION
Vertebral artery dissecting aneurysms (VADA) cause 3-5% of cases of subarachnoid hemorrhage (SAH), [28, 34] particularly in middle-aged men, [10] and can occasionally involve the posterior inferior cerebellar artery (PICA). Intracranial VADA results from a tear in the intima, degeneration of the media, or disruption of the internal elastic lamina, which lead to the formation of an intramural hematoma. [32, 35] e hematoma may be eccentric to the adventitia or intima; subadventitial dissection preferentially occurs in the VA alone and presents as aneurysmal enlargement and SAH whereas subintimal dissection preferentially involves the basilar artery and presents with luminal narrowing and brainstem ischemia. [34] Unruptured VADA may present with headache, ischemic symptoms (e.g., lateral medullary syndrome), or mass effect, and remain stable or even improve without treatment. [17] Alongside surgical and endovascular treatment options, conservative management may be considered. Due to its uncertain natural history, the management of unruptured lesions is controversial. However, ruptured VADA presents a precarious situation with a high propensity for subsequent rebleeding, estimated at 30-70% and typically occurring within hours to days of the initial event. [3, 28] In patients with rebleeding, the mortality rate is high and has been estimated near 50%. [28] erefore, ruptured VADA is treated emergently to prevent mortality and severe disability.
VADA is usually not amenable to treatment with standard clipping or coil embolization due to the morphology of the lesion. Involvement of branch vessels of the VA, for example, PICA, further complicates matters due to the need to preserve brainstem and cerebellar perfusion, limiting treatment options and resulting in worse outcomes. [36] Many endovascular and surgical treatment options for VADA have been proposed, and new developments such as flow-diverting stents continue to expand the armamentarium. However, the risks associated with these treatment options are not clearly understood in the context of VADA involving PICA, and there are other variables (e.g., arterial configuration, presence of collaterals, operator skill, and potential bleeding events from antiplatelet therapy following endovascular treatment) that may factor into favorable treatment outcomes.
Here, we report an illustrative case of a patient with VADA involving the origin of PICA, with anatomically poor collateral flow to PICA demonstrated on angiography. e patient was ultimately treated with a flow-diverting stent. Treatment options and considerations for treatment of this condition were reviewed.
ILLUSTRATIVE CASE History
A 57-year-old man with a history of hypertension and mechanical valve replacement, on warfarin, presented to Harbor-UCLA Medical Center after experiencing severe headache and decreasing level of consciousness; the precise time of onset was unknown. ere was no history of preceding trauma, tobacco use, or known connective tissue disorders. By the time of initial evaluation, the patient was unresponsive and did not withdraw to noxious stimulation. e Glasgow Coma Scale score was 5 (E1V1M3), corresponding to the World Federation of Neurosurgical Societies Grade 5. His clinical condition was assessed as Hunt and Hess Grade 5. e patient's international normalized ratio was in the therapeutic range; warfarin was held, and anticoagulation was reversed using prothrombin complex concentrate and Vitamin K.
Imaging
Noncontrast computed tomography (CT) imaging of the brain revealed diffuse hemorrhage in the subarachnoid cisterns and fourth ventricular hemorrhage (modified Fisher [14] Grade 4), with secondary mild obstructive hydrocephalus [ Figure 1 ]. CT angiography showed a focal vascular lesion arising from the distal right VA [ Figure 2a ]. Digital subtraction angiography further revealed a dissection of the distal aspect of the vessel and a broad-based, 5 mm aneurysm that involved the origin of a large PICA [ Figure 2b and Figure 3 ]. e right posterior communicating artery (posterior communicating artery (PCOM)) was not visualized. Injection of the left VA did not demonstrate any appreciable collateral flow to the right PICA territory, although a balloon occlusion test was not performed. ere was a normal variant short segment partial duplication of the right VA at the V2-V3 junction that was not involved by the dissection.
Treatment
e patient was intubated and an external ventricular drain (EVD) was placed, before initiation of antiplatelet therapy. He exhibited clinical improvement with ventricular drainage to the point where he was speaking, following commands, and moving all extremities, though he was somnolent and confused. Due to the improvement in the patient's neurological status, surgical and endovascular options were considered to (1) control the aneurysm and prevent imminent rebleeding and (2) avoid ischemia of the right PICA territory in light of lack of clear collateral perfusion. An occipital artery to PICA bypass or PICA-PICA bypass could achieve the latter objective; however, the presence of significant medical comorbidities disfavored a surgical approach. Proximal vessel sacrifice would ordinarily preserve PICA flow through retrograde flow from the left vertebral system but would perpetuate flow to the dissecting aneurysm and thus maintain the risk of rerupture. Entrapment of the lesion with proximal and distal coil embolization would protect the lesion, but antegrade flow in the PICA would be eliminated with a high risk of ischemia to the lateral medulla and cerebellum. Furthermore, it would remove a VA from the posterior circulation with unclear consequences, particularly during a period of subsequent high risk of vasospasm.
We ultimately opted to treat with the urgent placement of a flow-diverting stent (one day after initial presentation), which would with one maneuver protect the aneurysm and preserve flow through the right PICA and VA. e cell design of the stent would restore laminar flow in the native vessel, thus redirecting flow to the VA and eliminating focal turbulence that often perpetuates incompletely treated lesions. At the same time, the stent wall does not compromise flow to normal side-branching vessels (i.e., PICA). Although this is an off-label indication, we believed that it provided the best treatment solution for this patient due to the aforementioned risks of each alternative.
e patient was premedicated with a loading dose of dual antiplatelet therapy (650 mg aspirin and 600 mg clopidogrel) the day before the procedure. A 2.75 mm × 18 mm Pipeline flow-diverting stent was deployed across the dissecting aneurysm in the V4 segment of the vessel. Angiography showed slowing of flow and early partial thrombus formation in the aneurysm with preservation of flow to PICA [ Figure 3 ]. e Pipeline stent placement was also visualized on CT [ Figure 4 ]. To prevent stent thrombosis and potential stentrelated thromboembolic complications, the patient remained on the dual antiplatelet regimen medication protocol. Repeat angiography 2 days later demonstrated further reduction in the size of the aneurysmal sac with normal PICA flow.
Postprocedure course
e patient's course was complicated by atrial fibrillation with rapid ventricular response and pulmonary edema on the 1 st postprocedure day. His neurological status improved over subsequent days of hospitalization to the point where he was awake, responsive, following commands, and moving all extremities. He was treated for rhythm control and extubated. ere was no evidence of vasospasm or rebleeding at the repaired dissecting aneurysm on repeated angiography. e patient continued on a course of 325 mg aspirin and 75 mg clopidogrel daily to prevent stent thrombosis and was observed clinically to assess platelet function. ere were no signs of hyper-responsiveness to antiplatelet treatment.
On the 10 th postprocedure day, the patient developed a hemorrhage of the left thalamus and basal ganglia. An intraparenchymal hematoma measuring 6.7 cm × 5.7 cm × 5.5 cm was found on CT, with mass effect resulting in a 1 cm left-to-right midline shift and uncal herniation [ Figure 5 ]. His clinical status correspondingly deteriorated. Antiplatelet therapy was withheld until the hemorrhage was stable on CT, but unfortunately, the patient did not recover and expired on day 28.
REVIEW OF LITERATURE
e treatment of VADA illustrates the importance of carefully weighing treatment risks and benefits, taking into account multiple considerations: (1) preventing further rebleeding; (2) decreasing flow/promoting thrombosis to the aneurysm; (3) maintaining perfusion of the territory of the parent vessel; (4) maintaining perfusion of the branch vessels; (5) avoiding iatrogenic complications, for example, from use of antiplatelet or anticoagulant medications. Proposed treatment options possess unique combinations of these features. Broadly, they can be classified as deconstructive, in which the segment of the parent (vertebral) artery containing the aneurysm is excluded, thereby reducing the risk of bleeding, or reconstructive, in which the dissecting aneurysm is allowed to thrombose while maintaining normal flow through the parent artery. Surgical treatments open further possibilities, in which the PICA can be revascularized, or the aneurysmal segment can be bypassed.
e database PubMed was searched using the keywords "vertebral artery dissecting aneurysm" for articles published in the past 10 years, returning 873 articles. e articles were narrowed to English-language reports of case series of VADA. Reports of single cases were excluded. Each of these articles was read to identify whether the relationship of the aneurysm to the origin of PICA was reported. In total, 160 cases from 33 articles were identified, and their histories were reviewed [Supplementary Table 1] . e patients were comprised of 66% men and 34% women, ranging in age from 12 to 82 (median 47) years of age. Endovascular treatments utilized included deconstructive methods: proximal occlusion (20 cases) and parent artery trapping (24 cases), and reconstructive methods: conventional stent placement (12 cases), multiple stent placement (30 cases), stent-assisted coiling (38 cases), VA-PICA stent placement combined with parent artery trapping (4 cases), and flowdiverting stent placement (10 cases). Surgical treatments included surgical clipping (1 case) and various methods of bypass and revascularization (19 cases).
Nonoperative treatment
Experience in several cohorts indicates that VADA, when ruptured, is unstable and, if untreated, at high risk of rebleeding and subsequent mortality. [3, 28] However, the natural history, and therefore treatment, of unruptured VADA is less clear. Avoiding endovascular or surgical treatment altogether, in that case, may be a reasonable option followed by monitoring for progression of symptoms or aneurysmal growth. [44] Occasionally, nonoperative management has been attempted in patients presenting with ruptured VADA. Hashimoto et al. reported on a prospective cohort of 7 patients managed nonoperatively with sedation using fentanyl and blood pressure control using diltiazem or nicardipine, and none suffered from rebleeding in a mean 20-month follow-up time frame. [16] However, this strategy is fraught with risk. While stratification attempts have yielded intriguing results, [40] it remains challenging to identify patients with a low chance of rebleeding. It is therefore unsurprising that nonoperative management is rarely reported in more recent case series. Of the cases we reviewed, only one was managed nonoperatively, due to a hypoplastic contralateral VA; the eventual outcome was favorable. [39] However, given the body of evidence for a high propensity of rebleeding from untreated, ruptured VADA that threatens severe disability and death, treatment aimed at preventing these complications should take precedence. 
Proximal occlusion
Endovascular and open surgical methods exist for occlusion of the VA proximal to the aneurysm. Unilateral occlusion of the VA, if it does not affect branching or perforating vessels, usually results in good neurological outcome due to the supply of the basilar artery and VA distal to the occlusion by the contralateral VA. [38] However, the degree to which this is tolerated depends on the ability of the contralateral VA to provide this perfusion, which can be compromised with arterial pathology or in a nondominant artery. Furthermore, subsequent pathology in the remaining VA is much more difficult to treat after occlusion.
In cases involving PICA, this method is particularly attractive as it can maintain patency of distal branches by retrograde flow from the distal end of the VA. Unfortunately, with proximal occlusion the aneurysm is still open to retrograde flow from the contralateral VA and perhaps the basilar artery if there were patent PCOMs, therefore maintaining the dissecting aneurysm's ability to progress or bleed. [13, 22, 27, 28, 31] In a series of 47 patients with VADA involving PICA and treated with proximal occlusion in most cases, 21.3% experienced rebleeding or angiographic recurrence. [20] Other variations of a technique intended to address this issue, for example, occluding even more proximally in relation to the dissection, [23] also suffer from similar problems. Among the 20 cases treated with proximal occlusion reviewed here, 7 (35%) resulted in rebleeding, growth of the aneurysm, or infarction, reflecting the inadequate control of the aneurysm. Among four of these patients who presented with unruptured VADA, all had a good clinical outcome. Among the remaining 16 patients with ruptured VADA, two (12.5%) were complicated by rebleeding and death. ese cases provide evidence that proximal occlusion leaves open the possibility of further aneurysm growth and rupture.
Parent artery trapping
To more definitively control the dissecting aneurysm, the VA can be occluded both proximal and distal to the aneurysm (thereby completely excluding it from the circulation). For cases in which the origin of PICA is involved or nearby the aneurysm, this procedure would also sacrifice PICA with the compromise of its territory in the absence of robust collateral flow. Another less frequently discussed risk is the loss of the VA. e nondominant VA is usually considered safe to occlude, and even the dominant VA is frequently occluded, particularly if a large PCOM is present. However, following occlusion, the posterior circulation would almost entirely depend on the contralateral VA, which may not be sufficient or may suffer from contralateral disease involvement or resulting vasospasm.
Interestingly, this procedure has been performed in some cases without ischemic complications. [30] From the Japanese Registry of Neuroendovascular erapy 1, [36] PICA was involved in VADA in 50 cases. Of these, PICA was sacrificed in 23 and preserved in 23. Among cases in which PICA was occluded, procedural complications were reported in 34.8% of patients, and ischemic complications were reported in 21.7% patients, higher than the rate in the PICA-preserved group. e ability to withstand the loss of PICA is likely related to the quality of pial collaterals from the ipsilateral anterior inferior cerebellar artery (AICA) and superior cerebellar artery (SCA) and contralateral PICA. [21] Nonetheless, some authors have reported a high complication rate with parent artery trapping in patients with aneurysms involving PICA; in one case series, 2 of 42 in which the VADA was distal to PICA experienced medullary infarction, compared to 4 of 7 in which the VADA involved PICA. [1] Surprisingly, in our review of 24 cases treated with parent artery trapping, only one asymptomatic infarction in the PICA territory was documented. Incomplete occlusion was found in two cases. is relative success with parent artery trapping may result from the careful selection of patients who may tolerate obliteration of PICA. While the sacrifice of PICA is possible in some cases without neurological sequelae, particularly in cases with strong collateral supply to the PICA territory, it remains difficult to predict which patients may not tolerate this procedure.
Bypass
Trapping of an aneurysm involving PICA usually necessitates interrupting the antegrade flow through the branching vessel; however, multiple surgical approaches are available to revascularize PICA. PICA-PICA bypass, for example, can be performed in an elegant procedure that takes advantage of the anatomical proximity and similarity in the caliber of the two vessels. [5] Other approaches include occipital artery-PICA bypass, PICA re-implantation, or VA-PICA bypass with an interposition graft. [11] Trapping of the aneurysm and surgical revascularization of PICA can provide immediate, definitive treatment while still preserving PICA. Among 19 cases that were reviewed, two episodes of graft occlusion were reported (one asymptomatic and one causing symptomatic cerebellar infarction). ree other instances of infarction were also noted that may not have been related to the bypass procedure. Indeed, as this treatment is sometimes reserved for patients with few other options, the population may be over-represented with patients with more complicated presentations.
While bypass is very useful as a definitive treatment with a lower risk of rebleeding compared to endovascular methods, these procedures are technically challenging and require the patient to withstand surgery and its accompanying risks. [33] Furthermore, they depend on vascular anatomy that is amenable to the anastomosis, which is not possible in all instances. erefore, they have been typically reserved for cases not amenable to endovascular treatment, or that have failed endovascular treatment.
Traditional stents
In contrast to the deconstructive methods, stenting provides a reconstructive method that heals the aneurysm while maintaining patency of the parent artery. Stents may also support coil placement within the aneurysm that would otherwise be precluded by the lack of a distinct aneurysmal neck. Modifications to these procedures include stent placement from the contralateral VA to PICA, to maintain patency of retrograde flow; stent-assisted coiling with the distal end of the stent within PICA, to prevent occlusion of the PICA origin; [43] and placement of multiple overlapping stent methods to decrease the porosity of the stent wall and further exclude the aneurysm. [9] Risks to conventional stenting include insufficient redirection of flow away from the aneurysmal dilatation, leading to rebleeding, or aneurysmal progression. [18] In addition, if coiling is used for the false lumen, the wall of the aneurysm is fragile and may be prone to rupture. Furthermore, the use of stents necessitates antiplatelet or anticoagulant therapy, increasing the risk of bleeding. e superiority of antiplatelet over anticoagulant therapy has been demonstrated in the interventional cardiology literature. [37] e salience of this bleeding risk further increases in patients who require an EVD, and precautions should be taken to prevent intraparenchymal bleeds. Previous studies have found a relatively high risk of recurrence; in one series, 9 of 39 (23%) patients with ruptured VADA involving PICA and treated with stent-assisted coiling experienced either rebleeding or angiographic recurrence. [45] In the 12 patients reviewed that were treated with stent alone, aneurysm obliteration was incomplete in 8 (67%) by angiography, with one episode among these of rebleeding and death. e patient population may also have been biased toward relatively healthy patients. In the 38 patients treated with stent-assisted coiling, aneurysm obliteration was incomplete in 7 (18%) with four episodes of rebleeding and death and two episodes of cerebellar infarction. Curiously, the lack of aneurysmal obliteration did not always correspond to rebleeding; in one patient with complete obliteration, there was rebleeding, while many patients with incomplete obliteration did not experience any complications even after lengthy follow-up. Nonetheless, the high rebleeding rate suggests that stent placement is suboptimal for control of VADA.
Flow-diverting stents
e use of multiple overlapping stents offered high wall coverage and low porosity, thereby reducing blood flow to an aneurysmal dilatation while maintaining patency of the parent artery. Now, specialized stents have been designed to achieve this "flow-diverting" effect with a single device. While typical stents have wall coverage of 9-12%, flow-diverting stents may achieve wall coverage of 30-35%. [12] is decrease in flow leads to thrombosis and occlusion of the aneurysm followed by intimal remodeling and stent endothelialization that further excludes the aneurysm.
A major advantage of flow-diverting stents derives from the ability to occlude flow to the aneurysm while preserving parent artery blood flow, regardless of the fusiform shape. Furthermore, the flow-diverting stent may maintain transstent perfusion of branching vessels, for example, PICA, [19] with high rates of patency. [26] Despite these advantages, there is thought to be a higher risk of hemorrhagic and thromboembolic complications compared to alternative treatments, in one study with 8% symptomatic infarctions and 51% DWI changes. [41] Perforator infarction has been reported due to the high metal coverage of the stent but appears to be relatively rare. [7] e curious phenomenon of contralateral hemorrhage with no clear etiology, as our patient experienced, has also been reported occasionally, [29] and may be related to antiplatelet therapy, in which tiny vascular lesions occult to standard diagnostic imaging may hemorrhage. e rate of immediate aneurysm occlusion is poor, though it is unclear if there are any resultant increases in the risk of rebleeding. Finally, flow-diverting stents are more technically challenging to place, and procedure-related morbidity and mortality may improve as familiarity increases. [29] Literature of flow-diverting stents, including in the posterior circulation, has accumulated only recently, and conclusions are only now starting to solidify. Among the reviewed studies, there were 30 that reported on the use of multiple overlapping stents, with only one instance of rebleeding. In addition, there were 10 cases treated using flow-diverting stents, with complications in two (stent thrombosis and occlusion, and the intraparenchymal hemorrhage in this case). Between both groups, the risk of rebleeding was only 1 in 40, and PICA was patent in all cases. However, the immediate occlusion rate was poor. ese data suggest that, even though the flow-diverting stent is associated with variable degrees of angiographic improvement in the acute stage, the risk of rebleeding from the dissecting aneurysm is relatively low.
Other methods
Aside from surgical trapping, other surgical approaches are occasionally used for the treatment of VADA. Surgical aneurysm clipping offers an attractive option in saccular aneurysms, providing the most physiologic restoration of normal arterial flow with broad applicability to aneurysms at the VA-PICA junction. [24] While typically less amenable to clipping compared to saccular aneurysms, dissecting or fusiform aneurysms, have occasionally been treated by methods such as clipping or wrapping, although these alternatives carry the risk of rebleeding. [25] e lower third of the posterior circulation can be accessed by variations of the lateral or far-lateral suboccipital approach. [33] However, these techniques are especially challenging for dissecting aneurysms that often have fusiform morphology and friable walls without an easily clippable neck, and the additional challenge of PICA involvement necessitating preservation of parent artery flow. Surgical approaches also carry inherent risks; in particular, for surgery at the VA/PICA junction, the incidence of lower cranial nerve injury is high. [2, 25] Carefully selected patients may benefit from these surgical treatment methods, particularly when the aneurysm morphology is amenable to clipping and the perioperative risk is low.
Treatment strategy
e treatment of VADA continues to improve with new techniques, most notably the development of flow-diverting stents. However, the approach to VADA remains multifaceted and requires consideration of many variables including PICA involvement, rupture, angiographic appearance, and evidence of progression, collateral flow and VA dominance, and other patient and operator factors. e number of potential treatment options parallels these considerations. In a series of 190 patients with VA aneurysms (150 saccular and 42 fusiform), Lehto et al. described more than 20 different treatment methods used at a single institution. [25] e characteristics of a large number of imperfect surgical and endovascular options must be understood to optimize treatment.
Here, we reviewed literature for cases of VADA that involved PICA to clarify some of these points. Our study is limited by its design; as a retrospective literature review based on case series without standardized methods or inclusion criteria, the possibility for ascertainment bias, publication bias, differences in technique and skill, variable reporting standards, and other confounders inevitably confound the results. Indeed, as this is a rare entity, most of the reviewed literature consists of case series and the level of evidence is rather low. In the treatment of an individual patient, variables that cannot be controlled also factor in the response to treatment. However, the data presented point toward a general strategy for the management of this entity.
Due to the high risk of rebleeding leading to significant morbidity or mortality, the treatment of ruptured VADA must first focus on securing the aneurysm. Given the evidence presented in literature, we believe that parent artery trapping remains the most effective treatment in ruptured intracranial VADA, given sufficient distance of the aneurysm from PICA or other VA branches. Parent artery trapping has demonstrated a lower rate of rebleeding compared to proximal occlusion. e rate of immediate angiographic occlusion is also higher compared to the flow-diverting stent, which theoretically should yield better control of the vessel in the acute stage in which rebleeding is most likely. Furthermore, parent artery trapping obviates the risk of thromboembolic events from stent hardware or hemorrhage from dual antiplatelet treatment or anticoagulation. e disadvantage of trapping is the removal of one VA from the total flow of the posterior circulation. Two-thirds of patients have an incomplete circle of Willis. us, in view of the risk of compromise to the posterior circulation it would be important to know the total collateral circulation to the posterior circulation. Absence of one VA or qualitatively poor contribution from the anterior circulation through the PCOMs would be important factors in the selection of the treatment. e common belief that the patient can lose one VA if the other is patent is not backed by hard evidence that this assumption is true. [6] In ruptured VADA with PICA involvement, the priority remains securing the aneurysm to prevent rebleeding and death. However, due to the risks of medullary infarction (which can range from asymptomatic to life threatening), flow-diverting stents should be considered first-line treatment. As an example, in our case, the patient appeared to have poor collateral flow to the distribution of the involved PICA and an incomplete circle of Willis, thereby disfavoring parent artery trapping. Flow-diverting stent placement was performed, with excellent immediate angiographic outcome. Published outcomes are excellent and the devices maintain patency of PICA in most cases. Care should be taken with monitoring of platelet function and special consideration for intracranial operations, for example, EVD or VP shunt placement, due to antiplatelet therapy.
In some cases, especially those with strong collaterals, the sacrifice of PICA along with the parent artery in a trapping procedure would provide more definitive treatment and should be considered. Unfortunately, the presence of collaterals and the importance of PICA are difficult to assess quantitatively. Surgical treatment with bypass methods may be considered in cases where the anatomy does not lend itself to the previously mentioned endovascular approaches and in which the patient has an acceptable risk of surgical complications.
Despite the published success with flow-diverting stents, the total experience with this treatment is still in its infancy and the complications must be better understood. e FDAapproved indications for Pipeline stenting in the United States have recently expanded to include intracranial aneurysms of the internal carotid artery (ICA) from the petrous ICA to the carotid terminus; flow diversion of the posterior circulation is, therefore, an off-label use. In addition, the optimal antiplatelet treatment strategy to prevent thromboembolic complications has not been determined. e most common regimen is preprocedural and postprocedural dual antiplatelet therapy with aspirin and clopidogrel, with discontinuation of clopidogrel and reduction of aspirin dose over time, though heterogeneity exists in the dosages used, duration of therapy, and use of platelet function testing. [15] Clopidogrel suffers from nonuniform response among patients, and therefore, the degree of platelet inhibition must be monitored. Hyporesponders and nonresponders comprise 16-50% of the population and are prone to thromboembolic complications; a smaller fraction of patients are hyperresponders and may be prone to hemorrhagic complications, although the clinical data are not definitive. [42] Alternatives to clopidogrel, including ticagrelor and prasugrel, provide a more homogeneous response across patients with a more rapid onset of action and may be used for initial treatment or more commonly, in clopidogrel nonresponders. [4] Likewise, platelet function tests (such as light transmission aggregometry, impedance whole blood aggregometry, and the VerifyNow P2Y12 assay) may help guide antiplatelet treatment, but there exists uncertainty regarding the precision of the result and superiority over clinical observation in both the neuroendovascular and percutaneous coronary intervention literature. [8, 15, 42] In the reported case, the Pipeline stent resulted in initial improvement and angiographic resolution. Subsequently, the patient developed a massive contralateral intraparenchymal hemorrhage that unfortunately led to death, even with precautions regarding intracranial instrumentation. While reported infrequently in literature, the optimal strategies for identification of at-risk patients and titration of antiplatelet therapy are still being clarified; more experience with flow diversion is needed. In the meantime, flow-diverting stents appear to be a promising solution at present for a condition with no ideal treatment options.
CONCLUSION
ese guidelines provide a framework for considering the treatment options for ruptured, intracranial VADA, particularly involving PICA. However, uncertainty continues to surround the treatment of this precarious condition. e collateral flow of PICA and the competency of the contralateral VA are difficult to quantify precisely, and therefore the operative risk of ischemia to these important arterial distributions can only be approximated. Furthermore, the success of treatment (as measured by immediate angiography) does not seem to be highly correlated with the durability of outcome, in instances of using conventional and flow-diverting stents. Efforts in identifying predictors of clinical outcome and treatment complications will be important to determine the optimal treatment option for individual patients.
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